BRKR · Bruker Corp · Executive Compensation
Market Cap
$8.28B
Shares
155.12M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Frank Laukien | Chairman, President and Chief Executive Officer | $4,706,388 |
| Mark R. Munch | Executive Vice President & President, | $2,178,054 |
| Gerald Herman | Executive Vice President and Chief Financial Officer | $2,010,308 |
| Bruker NANO Group | Juergen W. Srega President, | $1,422,590 |
| Falko Busse | Ph.D. President, | $1,420,798 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Frank Laukien | Chairman, President and Chief Executive Officer | $5,527,304 |
| Mark R. Munch | Executive Vice President & President, | $2,642,108 |
| Gerald Herman | Executive Vice President and Chief Financial Officer | $2,288,269 |
| Bruker BioSpin Group | — | $1,859,831 |
| Bruker NANO Group | Juergen W. Srega President, | $1,522,279 |
| Bruker CALID Group | — | $1,522,279 |
| Falko Busse | Ph.D. President, | $1,465,032 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Frank Laukien | Chairman, President and Chief Executive Officer | $5,858,761 |
| Mark R. Munch | Executive Vice President & President, | $2,726,522 |
| Gerald Herman | Executive Vice President and Chief Financial Officer | $2,204,302 |
| Bruker CALID Group | — | $1,472,236 |
| Bruker NANO Group | Juergen Srega President, | $1,472,236 |
| Falko Busse | Ph.D. President, | $1,345,365 |
| Bruker BioSpin Group | — | $1,345,365 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Frank Laukien | Chairman, President and Chief Executive Officer | $5,057,195 |
| Mark R. Munch | Executive Vice President & President, | $2,501,229 |
| Bruker NANO Group | Juergen W. Srega President, | $2,501,229 |
| Gerald Herman | Executive Vice President and Chief Financial Officer | $1,898,666 |
| Bruker CALID Group | — | $1,280,420 |
| Juergen W. Srega | President, Bruker CALID Group | $1,280,420 |
| Falko Busse | President, Bruker BioSpin Group | $1,150,440 |
| Bruker BioSpin Group | — | $1,150,440 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Frank Laukien | Chairman, President and Chief Executive Officer | $5,594,539 |
| Mark R. Munch | Executive Vice President & President Bruker Nano Group | $2,582,565 |
| Bruker NANO Group | Juergen Srega President, | $2,582,565 |
| Gerald Herman | Executive Vice President and Chief Financial Officer | $1,940,547 |
| Juergen W. Srega | President, Bruker CALID Group | $1,600,210 |
| Bruker CALID Group | — | $1,600,210 |
| Falko Busse | President, Bruker BioSpin Group | $1,103,967 |
| Bruker BioSpin Group | — | $1,103,967 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Frank Laukien | Chairman, President and Chief Executive Officer | $4,081,963 |
| Mark R. Munch | Executive Vice President & President Bruker Nano Group | $1,767,427 |
| Gerald Herman | Executive Vice President and Chief Financial Officer | $1,303,121 |
| Juergen W. Srega | President, Bruker CALID Group | $1,266,666 |
| Falko Busse | President, Bruker BioSpin Group | $871,812 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Frank Laukien | Chairman, President and Chief Executive Officer | $4,909,641 |
| Mark R. Munch | Executive Vice President & President Bruker Nano Group | $1,697,249 |
| Juergen W. Srega | President, Bruker CALID Group | $1,327,857 |
| Gerald Herman | Executive Vice President and Chief Financial Officer | $1,248,193 |
| Falko Busse | President, Bruker BioSpin Group | $950,030 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Frank Laukien | Chairman, President and Chief Executive Officer | $4,479,899 |
| Bruker NANO Group | — | $1,820,807 |
| Mark R. Munch | Executive Vice President & President | $1,820,807 |
| Juergen W. Srega | President, Bruker CALID Group | $1,390,793 |
| Gerald Herman | Chief Financial Officer | $1,026,521 |
| Falko Busse | President, Bruker | $699,245 |
| BioSpin Group | — | $699,245 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Frank Laukien | Chairman, President and Chief Executive Officer | $4,872,009 |
| Mark R. Munch | Executive Vice President & President | $1,851,936 |
| CALID Group | — | $1,355,291 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Thierry L. Bernard | director | Appointed | 2026-04-01 |
| Jack J. Phillips | director | Appointed | 2025-12-09 |
| John A. Ornell | Class I director | Appointed | 2025-05-29 |
| Frank H. Laukien, Ph.D. | Class I director | Appointed | 2025-05-29 |
| Richard A. Packer | Class I director | Appointed | 2025-05-29 |
| Bonnie H. Anderson | Class I director | Appointed | 2025-05-29 |
| Laura Francis | director | Appointed | 2025-02-21 |
| Thomas Bures | Chief Accounting Officer | Appointed | 2025-01-16 |
| Dr. Philip Ma | the Board | Resigned | 2024-08-07 |
Key facts
CIK
1109354
CUSIP
116794108
13F (30d)
204 filings
203 filers
Visit website
Investor relations